Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC Design
Jinyi Liang, Yuyang Liu, Man Zhao, Lu Chen, Jiajie Qin, Wenjing Ma, Ying Wang, Haiqiang Wu, Ruilin Tian, Tianzi Wei, Lingyin Lao, Jingfei Wang, Hengyu Qu, Hongbo Wang, Rongfang Gao, Sihan Guo, Ming Z
Journal:JOURNAL OF MEDICINAL CHEMISTRY
IF:7.3
DOI:10.1021/acs.jmedchem.5c02188
PMID:41628916
Published:2026-02-02
research field:神经科学分子生物学药理学
Abstract
E3 ligases are crucial to PROTAC technology, and identifying novel E3 ligase ligands could accelerate the advancement of PROTACs. DCAF11 has shown considerable potential for PROTAC applications. However, the ligands targeting DCAF11 remain limited, highlighting the need for the development of novel ligands for this E3 ligase. In this study, leveraging previous research on DCAF11 ligands, we designed a class of arylidene-thiazoldione scaffolds and applied it to develop PROTACs, resulting in the identification of a potent BRD4 degrader, LGF308. Degradation activity and mechanistic studies demonstrated that the compound LGF308 efficiently induces BRD4 degradation through the proteasomal pathway and via recruitment of DCAF11. This scaffold represents a reliable ligand, capable of facilitating the degradation of various proteins, including CDK4/6, BTK, and FKBP12. Therefore, this study introduces the arylidene-thiazoldione scaffold as a novel DCAF11 ligand and validates its application in PROTAC design, providing strong support for the development of DCAF11-based PROTACs.
本文使用的Yeasen产品


